Evidence map›Paper›PMID 40950867›Full record

ArticleJournal of thoracic disease2025

Comparison of surgical outcomes in patients with heart failure with reduced ejection fraction combined with moderate ischemic mitral regurgitation: a single-center retrospective study.

Wei Li, Wenxiao Huang, Jubing Zheng, Lisong Wu, Ran Dong

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wei Li *Department of Cardiovascular Surgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Wenxiao Huang *Department of Diagnostic Radiology, General Hospital of Southern Theater Command, PLA, Guangzhou, China.
Jubing ZhengDepartment of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
Lisong WuDepartment of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
Ran DongDepartment of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Coronary artery bypass grafting (CABG) is associated with a high surgical risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate ischemic mitral regurgitation (IMR). This study aimed to compare clinical outcomes between isolated CABG and combined CABG plus mitral valve surgery (MVS) in this population. Methods: This was a single-center, retrospective cohort study analyzing the clinical data of patients with coronary artery disease (CAD) combined with HFrEF and moderate IMR who underwent surgical revascularization. Patients with off-pump CABG were excluded to eliminate the possible effects of cardiopulmonary bypass (CPB). Finally, 158 patients were divided into CABG-alone group (n=117) and combined-MVS group (n=41). Clinical data and follow-up results were then compared. Results: Perioperative mortality was 7.6% (12/158), with no difference between groups [CABG-alone 6.8% Conclusions: Combined CABG plus MVS may reduce the recurrence rate of MR at 1 year postoperatively and improve the NYHA cardiac function class in high-risk patients with HFrEF and moderate IMR, but survival outcomes did not differ from isolated CABG. These findings support isolated CABG as a viable option.

Indexed as

coronary artery bypass graft (CABG)heart failure with reduced ejection fraction (HFrEF)Ischemic mitral regurgitation (IMR)mitral valve surgery (MVS)

Identifiers

PMID40950867
PMCPMC12433141

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.